Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Physician‑dispensed specialty drugs for cancer at issue as lawmakers debate anti‑steering protections
Summary
Senate Bill 975 would bar steering of oncology specialty drugs to PBM‑owned or preferred pharmacies and allow provider dispensing when clinically appropriate, with reimbursement protections for community practices.
Sen. Clarence Lam presented Senate Bill 975 to the Senate Finance Committee on Feb. 26, framing the bill as an effort to prevent pharmacy benefit managers and insurers from steering patients requiring specialty drugs—particularly oral oncology medications—to PBM‑owned or otherwise preferred pharmacies and to allow provider‑based dispensing when clinically appropriate.
Lam and testifying oncologists said physician‑integrated dispensing (sometimes called medically integrated dispensing or MID) can improve…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
